Bernadette Skorupska v. HHS - Hib, infantile spasms and related seizures and neurodevelopmental impairments, as well as a significant aggravation of his “developmental problems characterized by motor difficulties and hypotonia.” (2026)

Filed 2016-11-15Decided 2026-02-10Vaccine Hib
deniedcognitive/developmental

Case summary [AI summaries can sometimes make mistakes]

On November 15, 2016, Bernadette Skorupska filed a petition on behalf of her minor child, N.S., alleging that a Haemophilus influenzae type b (Hib) vaccination administered on November 16, 2013 caused infantile spasms, seizures, neurodevelopmental impairments, and significant aggravation of preexisting developmental problems marked by motor difficulties and hypotonia. N.S. was about eight months old at vaccination.

N.S. had pre-vaccination developmental concerns. After vaccination, the asserted vaccine-related course included spasms beginning at least four days later and later genetic testing showing an SCN2A mutation.

Petitioner's experts, including Dr. Georges Ghacibeh and Dr.

Mahbubul Huq, argued that vaccination caused harmful inflammation that triggered epilepsy and severe developmental regression, and that the SCN2A mutation would otherwise have caused a milder picture. Respondent, relying on Dr.

Gerald Raymond and literature concerning SCN2A-related epileptic encephalopathy, argued that the genetic mutation alone explained the neurologic course. Special Master Christian J.

Moran denied compensation. He found no persuasive evidence of the harmful post-vaccination inflammation central to petitioner's theory, found that the SCN2A mutation preponderantly explained the infantile spasms and developmental problems, and held that the timing proof was insufficient.

The decision also treated the genetic condition as an alternative cause. No injury compensation was awarded.

Theory of causation

Minor child, about 8 months; Hib vaccine November 16, 2013; alleged infantile spasms/seizures/neurodevelopmental impairment and significant aggravation of preexisting motor difficulty/hypotonia. DENIED. Petitioner experts Dr. Ghacibeh and Dr. Huq proposed vaccine inflammation triggering epilepsy/regression despite SCN2A mutation; respondent expert Dr. Gerald Raymond attributed course to SCN2A mutation. SM Moran found no persuasive post-vaccine inflammation, timing not supportive, and SCN2A the preponderant cause. Petition filed November 15, 2016; decision February 10, 2026.

Source PDFs 2 total · 1 downloaded